Clinical Trials

63 enrolled

Head & Neck

Locally Advanced Head and Neck Carcinoma

NCT04253080 2026-05-20

ENZYMELA

127 enrolled

Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT06086704 2026-05-18

Study of 18F-FFNP Breast PET/MRI

53 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07588698 2026-05-15

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

20 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07579507 2026-05-12

HOPES

Phase NA Not yet recruiting

150 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04202094 2026-05-06

Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

Phase NA Enrolling by invitation

50 enrolled

Hematologic Diseases, Neoplasms

NCT04331067 2026-05-06

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Phase 1/2 Active not recruiting

15 enrolled 12 charts

Triple Negative Breast Neoplasms

NCT04680117 2026-05-06

SevAsthma

54 enrolled

Lymphoid

Asthma, Lymphoma, Follicular

NCT05119244 2026-05-06

ECP

150 enrolled

Marijuana Abuse, Lung Neoplasms

NCT05354765 2026-05-06

ALCYTA

300 enrolled

Neoplasms

NCT06127979 2026-05-05

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

42 enrolled

Phase 1 Active not recruiting

Breast Neoplasms

NCT03465618 2026-05-01

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

17 enrolled

CNSEndocrine

Brain Neoplasms, Pituitary Neoplasms

NCT06682442 2026-05-01

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Phase NA Active not recruiting

66 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT07560865 2026-05-01

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Phase 1 Recruiting

9 enrolled

CNS

Astrocytoma, Glioblastoma, Disease Progression

NCT04222335 2026-04-29

LUNG-RESIST

80 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05306912 2026-04-29

KOBE

Lung Neoplasms

NCT06247826 2026-04-29

RESAMEX

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06620835 2026-04-29

OPTALK

45 enrolled

Phase NA Not yet recruiting

Lung Neoplasms

NCT07555600 2026-04-29

E-FACTOR

300 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT06861244 2026-04-23

PNOC031

70 enrolled

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

NCT02342158 2026-04-21

PERMED01

550 enrolled

Phase 2 Enrolling by invitation

Neoplasm Metastasis

NCT07542158 2026-04-21

Ultralow Dose PET Imaging of 18F-FDOPA

200 enrolled

CNS

Glioma, Neoplasms, Parkinsonian Disorders

NCT02557061 2026-04-16

TIL

56 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02872779 2026-04-16

COCA-MACS

74 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06666803 2026-04-16

Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)

Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT03348891 2026-04-14

MELANFα

Dermatologic

Melanoma

NCT05088395 2026-04-14

ALCINA4

2,050 enrolled

Neoplasms

NCT06020651 2026-04-08

VICKI

39 enrolled

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Neoplasms, Vascular Diseases, Atherosclerosis

NCT07284589 2026-04-08

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

200 enrolled

Phase 2 Active not recruiting

Neoplasms

NCT04412629 2026-04-06

Cabozantinib in High Grade Neuroendocrine Neoplasms

35 enrolled

Endocrine

High Grade Neuroendocrine Neoplasms

NCT04141462 2026-04-03

EX²TRICAN

613 enrolled

Neoplasms, Genetic Predisposition to Disease

NCT02613962 2026-04-01

MAPPYACTS

791 enrolled

Neoplasms, Recurrence

NCT02822404 2026-04-01

CysPed

42 enrolled

Kidney Diseases

NCT07054346 2026-04-01

LUTACT

Phase 1 Recruiting

45 enrolled

Phase 4 Not yet recruiting

Disease, Prostatic Neoplasms

NCT07490509 2026-04-01

DOSABEMA

235 enrolled

Breast Neoplasms

NCT02133222 2026-03-31

AMMAM

Phase 2 Active not recruiting

22 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT04067726 2026-03-31

TRIDENT

210 enrolled

Breast Neoplasms

NCT05981326 2026-03-31

NEOEPICURE

300 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT02867033 2026-03-30

ALTITUDES

628 enrolled

Sarcoma

Desmoid Tumors

NCT04167969 2026-03-27

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Phase 1 Recruiting

16 enrolled

Prostatic Neoplasms

NCT05754892 2026-03-27

COMETE-CARE

450 enrolled

Neoplasms

NCT06435546 2026-03-27

AdOTAC

200 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07276360 2026-03-27

HypoRTCx-UG

Phase EARLY_PHASE1 Terminated

278 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05204290 2026-03-24

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

1 enrolled

Neoplasms, Epidural Neoplasms

NCT05212272 2026-03-23

MRI in High-Grade Glioma Patients Undergoing Chemoradiation

16 enrolled

CNS

Glioma

NCT03010124 2026-03-20

OvBIOMark

350 enrolled

Gynecologic

Ovarian Neoplasms

NCT05595577 2026-03-20

PALS

110 enrolled

BreastLymphoid

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT05692635 2026-03-20

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Phase NA Active not recruiting

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03185039 2026-03-19

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

50 enrolled